JOE CUTRER: Open Payments
NPI 1750311205 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,675 in 113 payments from 35 companies in 2025. Trend: 2023 $2,885 · 2024 $3,296 · 2025 $2,675
Food & beverage: $2,582Education: $93
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $249 |
| Incyte Corporation | 9 | $236 |
| ABBVIE INC. | 8 | $206 |
| Merck Sharp & Dohme LLC | 8 | $186 |
| E.R. Squibb & Sons, L.L.C. | 9 | $178 |
| Janssen Biotech, Inc. | 8 | $169 |
| PFIZER INC. | 7 | $166 |
| Daiichi Sankyo Inc. | 5 | $117 |
| BeOne Medicines USA, Inc. | 4 | $100 |
| ARRAY BIOPHARMA INC | 6 | $93 |
Products named: KEYTRUDA, OPDIVO, EPKINLY, KISQALI, PLUVICTO, MONJUVI, IBRANCE, TEVIMBRA.
Industry payments across TX — which companies pay providers there.
